3 Firms Seek To Rep Biogen Investors In Securities Fraud Suit

Law360 (January 13, 2021, 11:25 PM EST) -- The Rosen Law Firm PA, Lowey Dannenberg PC and Pomerantz LLP all want to represent a proposed class of investors in a securities fraud suit in California federal court alleging Biogen Inc. and three of its executives misrepresented the odds of success that one of the pharmaceutical company's drugs has with the U.S. Food and Drug Administration.

In three motions filed Tuesday, the firms asked U.S. District Judge James V. Selna to appoint them lead counsel in the matter and to appoint their clients lead plaintiffs, or co-lead plaintiffs in the case of one motion.

The first motion docketed was filed...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!